Fibrocell repurposes anti-wrinkle treatment plant for gene therapy candidate – BioPharma-Reporter.com
BioPharma-Reporter.com |
Fibrocell repurposes anti-wrinkle treatment plant for gene therapy candidate
BioPharma-Reporter.com In June 2016, the autologous cell and gene therapy company announced it was winding down its Laviv axficel-T operations after missing the primary endpoints a Phase II clinical trial the treatment of vocal cord scarring resulting in chronic or severe … |
